PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+7.35%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$176M
AUM Growth
+$176M
(+1.9%)
Cap. Flow
-$3.2M
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
34.97%
Holding
113
New
8
Increased
24
Reduced
31
Closed
7
Top Buys
| 1 |
SRXH
SRX Health Solutions, Inc.
SRXH
|
$1.29M |
| 2 |
Achieve Life Sciences
ACHV
|
$1.18M |
| 3 |
ASPU
ASPEN GROUP, INC.
ASPU
|
$1.15M |
| 4 |
BIOL
Biolase, Inc.
BIOL
|
$1.02M |
| 5 |
Perion Network
PERI
|
$811K |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$4.02M |
| 2 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$1.92M |
| 3 |
SHSP
SharpSpring, Inc.
SHSP
|
$1.79M |
| 4 |
Sonim Technologies
SONM
|
$1.49M |
| 5 |
INTZ
INTRUSION INC NEW
INTZ
|
$1.4M |
Sector Composition
| 1 | Healthcare | 61.86% |
| 2 | Technology | 15.69% |
| 3 | Communication Services | 6.71% |
| 4 | Industrials | 5.33% |
| 5 | Consumer Staples | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CareDx
CDNA
$727M
| $9.39M | 5.33% | 102,642 -3,500 | -3% | -$320K |
|
2
OptimizeRx
OPRX
$335M
| $7.21M | 4.09% | 116,430 -5,276 | -4% | -$327K |
|
3
NeoGenomics
NEO
$1.13B
| $7.15M | 4.06% | 158,300 -2,500 | -2% | -$113K |
|
4
Natera
NTRA
$23.1B
| $7.09M | 4.02% | 62,450 -1,500 | -2% | -$170K |
|
5
Idexx Laboratories
IDXX
$51.8B
| $7.01M | 3.98% | 11,105 | – | – |
|
6
Axogen
AXGN
$743M
| $5.9M | 3.35% | 272,840 -4,650 | -2% | -$100K |
|
7
Veracyte
VCYT
$2.39B
| $5M | 2.84% | 124,980 -1,500 | -1% | -$60K |
|
8
FlexShopper
FPAY
$17M
| $4.39M | 2.49% | 1,479,370 +100,000 | +7% | +$297K |
|
|
CSLT
9
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $4.3M | 2.44% | 1,633,000 +173,500 | +12% | +$456K |
|
10
Microsoft
MSFT
$3.77T
| $4.2M | 2.38% | 15,493 | – | – |
|
|
11
Vericel Corp
VCEL
$1.83B
| $4.13M | 2.34% | 78,612 -76,495 | -49% | -$4.02M |
|
12
Inuvo
INUV
$49.5M
| $4M | 2.27% | 4,147,511 +364,898 | +10% | +$352K |
|
|
STRM
13
DELISTED
Streamline Health Solutions
STRM
| $3.43M | 1.95% | 1,937,950 -40,600 | -2% | -$71.9K |
|
14
Cantaloupe
CTLP
$797M
| $3.3M | 1.87% | 277,975 -1,250 | -0.4% | -$14.8K |
|
15
Standard BioTools
LAB
$481M
| $3.21M | 1.82% | 520,825 -20,000 | -4% | -$123K |
|
16
Abbott
ABT
$231B
| $3.2M | 1.81% | 27,580 | – | – |
|
17
LeMaitre Vascular
LMAT
$2.16B
| $3.16M | 1.79% | 51,800 -1,950 | -4% | -$119K |
|
18
Eli Lilly
LLY
$657B
| $3.15M | 1.79% | 13,708 | – | – |
|
19
AtriCure
ATRC
$1.84B
| $3.04M | 1.73% | 38,350 | – | – |
|
20
Exagen
XGN
$217M
| $3.01M | 1.71% | 200,480 -3,050 | -1% | -$45.7K |
|
|
AVGR
21
DELISTED
Avinger, Inc. Common Stock
AVGR
| $2.91M | 1.65% | 2,366,500 +635,500 | +37% | +$782K |
|
22
Alphatec Holdings
ATEC
$2.35B
| $2.71M | 1.54% | 176,750 -7,000 | -4% | -$107K |
|
23
Digi International
DGII
$1.29B
| $2.55M | 1.45% | 126,800 -1,500 | -1% | -$30.2K |
|
24
Rockwell Medical
RMTI
$58.9M
| $2.53M | 1.43% | 2,774,675 -63,500 | -2% | -$57.8K |
|
25
Ooma
OOMA
$356M
| $2.44M | 1.38% | 129,225 +9,425 | +8% | +$178K |
|